Market Cap

PhotoCure ASA Market Capitalization:

kr1.58 Billion

NOK as of July 1, 2024

US$148.3 Million

business PhotoCure ASA Company Profile

PhotoCure ASA Main Stock Listings

Market Capitalization History of PhotoCure ASA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of PhotoCure ASA market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr1.75 B -42.36%
Jan. 1, 2023 kr3.03 B 18.09%
Jan. 1, 2022 kr2.57 B -6.31%
Jan. 1, 2021 kr2.74 B 19.90%
Jan. 1, 2020 kr2.29 B 89.60%
Jan. 1, 2019 kr1.21 B 74.56%
Jan. 1, 2018 kr690.8 M -42.39%
Jan. 1, 2017 kr1.20 B 15.18%
Jan. 1, 2016 kr1.04 B 0.53%
Jan. 1, 2015 kr1.04 B 47.86%
Jan. 1, 2014 kr700.4 M -32.19%
Jan. 1, 2013 kr1.03 B -2.82%
Jan. 1, 2012 kr1.06 B -25.36%
Jan. 1, 2011 kr1.42 B 16.11%
Jan. 1, 2010 kr1.23 B 94.81%
Jan. 1, 2009 kr629.5 M -40.77%
Jan. 1, 2008 kr1.06 B -23.53%
Jan. 1, 2007 kr1.39 B 0.00%
Jan. 1, 2006 kr1.39 B 39.73%
Jan. 1, 2005 kr994.7 M -42.97%
Jan. 1, 2004 kr1.74 B 68.42%
Jan. 1, 2003 kr1.04 B -67.52%
Jan. 1, 2002 kr3.19 B 17.00%
Jan. 1, 2001 kr2.73 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

PhotoCure ASA Categories

languages Healthcare languages Drug Manufacturers—Specialty & Generic

Stocks & Indices

PhotoCure ASA has the following listings and related stock indices.


Stock: OSE: PHO

Stock: OSE: PHOO

Stock: FSX: PHS

Stock: OTC: PHCUF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.